Ardent Health (NYSE:ARDT) Stock Price Target Raised at Royal Bank Of Canada

Ardent Health (NYSE:ARDT) had its price target upped by investment analysts at Royal Bank Of Canada from $13.00 to $18.00 in a note issued to investors on Friday, Benzinga reports. The brokerage currently has an “outperform” rating on the stock. Royal Bank Of Canada‘s price objective would suggest a potential upside of 2.69% from the stock’s previous close.

A number of other research analysts also recently weighed in on ARDT. Weiss Ratings upgraded Ardent Health from a “sell (d)” rating to a “sell (d+)” rating in a report on Tuesday, October 6th. BMO Capital Markets began coverage on Ardent Health in a research report on Tuesday, September 22nd. They issued a “market perform” rating and a $11.00 target price for the company. Wall Street Zen cut Ardent Health from a “buy” rating to a “hold” rating in a research note on Sunday, July 12th. Guggenheim raised their target price on Ardent Health from $13.00 to $14.00 and gave the company a “buy” rating in a research note on Thursday, August 6th. Finally, The Goldman Sachs Group restated a “neutral” rating and set a $13.00 price target on shares of Ardent Health in a research report on Thursday, August 6th. Seven investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and two have given a Sell rating to the company’s stock. According to data from MarketBeat.com, Ardent Health has an average rating of “Hold” and an average target price of $13.21.

Ardent Health Trading Up 10.2%

ARDT traded up $1.63 on Friday, hitting $17.53. 1,301,469 shares of the company were exchanged, compared to its average volume of 467,865. The company has a debt-to-equity ratio of 0.61, a quick ratio of 1.99 and a current ratio of 2.10. The firm has a fifty day simple moving average of $11.32 and a two-hundred day simple moving average of $10.05. The stock has a market capitalization of $2.47 billion, a PE ratio of 17.02, a price-to-earnings-growth ratio of 3.68 and a beta of 0.58. Ardent Health has a 12 month low of $7.71 and a 12 month high of $17.59.

Ardent Health (NYSE:ARDT) last issued its quarterly earnings data on Wednesday, November 4th. The company reported $0.31 EPS for the quarter, beating the consensus estimate of $0.23 by $0.08. The firm had revenue of $1.62 billion during the quarter, compared to the consensus estimate of $1.60 billion. Ardent Health had a net margin of 2.27% and a return on equity of 8.49%. Sell-side analysts expect that Ardent Health will post 0.96 earnings per share for the current year.

Institutional Trading of Ardent Health

Large investors have recently made changes to their positions in the stock. BlackRock Inc. bought a new stake in Ardent Health in the 2nd quarter worth approximately $21,415,000. Algert Global LLC lifted its holdings in shares of Ardent Health by 1,277.3% during the 2nd quarter. Algert Global LLC now owns 597,745 shares of the company’s stock valued at $5,882,000 after buying an additional 554,345 shares during the period. Empowered Funds LLC bought a new position in shares of Ardent Health during the 2nd quarter valued at $5,425,000. Bank of America Corp DE bought a new position in shares of Ardent Health during the 2nd quarter valued at $3,840,000. Finally, Bank of New York Mellon Corp purchased a new position in shares of Ardent Health in the 2nd quarter worth $2,377,000.

Ardent Health Company Profile

Ardent Health is a U.S. healthcare services company that operates hospitals, outpatient facilities and physician practices. Its services include emergency and acute care, surgery, cardiology, orthopedics, oncology, women’s health, behavioral health, rehabilitation, imaging and other specialty and primary care offerings.

The company serves patients through regional health networks and hospital campuses primarily in Texas, Oklahoma, New Mexico and other U.S. markets. In addition to hospital-based care, Ardent operates outpatient clinics, urgent care locations and other facilities designed to provide services across different stages of the patient-care process.

Ardent Health was founded in 2001 and became a publicly traded company on the New York Stock Exchange in 2024.